UniDoc Health Corp (UDOC) AI Stock Analysis

• Market Cap: C$11.66M
• Dividend Yield: N/A
• Average Volume (3M): 67.00K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.04
• Revenue Growth: N/A
• EPS Growth: 48.94%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 86,350,090
• 10 Day Avg. Volume: 18,137
• 30 Day Avg. Volume: 67,001
• PEG Ratio: -0.02
• Price to Book (P/B): 28.14
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: C$0.13 ▼(-5.71% Downside)
• Action: Reiterated Date: 03/15/26
• Date: Action: Reiterated 03/15/26

The score is primarily constrained by weak financial performance—large losses, significant cash burn, and negative equity—despite strong recent revenue growth. Technicals are mixed (neutral momentum but still below key longer-term moving averages), and valuation is difficult to support with a negative P/E and no dividend yield provided.

Positive Factors

Integrated telemedicine platform

UniDoc’s H3 Health Cubes combine remote consultations with on-site diagnostic capabilities, creating a differentiated, productized telehealth offering. That integrated hardware+software stack supports stickier customer relationships, recurring services, and data-driven improvements that sustain competitive advantage over months.

Strong trailing revenue growth

Sustained 52% TTM top-line growth indicates early market traction and accelerating adoption of UniDoc’s platform. For a healthcare IT business, steady revenue expansion can enable fixed-cost absorption and margin improvement as scale builds, underpinning a path toward durable profitability if growth continues.

Low absolute debt burden

Minimal reported debt reduces near-term bankruptcy and interest-service risk, preserving operational flexibility. With low financial leverage, management can focus fundraising on growth investments or working capital without immediate large debt repayments, a structural plus during scaling.

Negative Factors

Persistent cash burn

Consistent negative operating and free cash flow (millions annually) means the company depends on external funding to sustain operations. Over 2–6 months this constrains strategic options, increases dilution risk from capital raises, and limits the ability to invest in product and sales until cash conversion turns positive.

Negative equity position

Negative equity reflects accumulated losses and episodic equity swings, signaling weakened balance-sheet cushions. This impairs financial flexibility, raises creditor and investor concerns, and makes the company more likely to rely on dilutive financing or restrictive terms, a structural governance and funding risk.

Low gross margin; deeply negative operating margins

Modest gross margins and heavily negative operating margins show the current cost structure overwhelms revenue. Unless UniDoc materially improves margins through pricing, product mix, or scale, profitability remains distant. This structural margin gap undermines durable cash generation prospects.

UniDoc Health Corp Business Overview & Revenue Model

Company Description

UniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada. It offers Virtual Health Clinics, a customizable solution that offers safe and secure ways to connect patients in urban, rural, and remote locations with medical care, as well as delivers rapid and real-time diagnostic testing, and supplies therapeutic treatment with continued health monitoring. The company was formerly known as Unicheck Holdings Corp. and changed its name to UniDoc Health Corp. in April 2021. UniDoc Health Corp. was incorporated in 2021 and is based in Vancouver, Canada.

How the Company Makes Money

null

UniDoc Health Corp Financial Statement Overview

Summary

Despite strong TTM revenue growth (+52.0%), profitability and cash generation are very weak: deeply negative operating results and materially negative operating/free cash flow (~-$3.0M/~-$3.3M). The balance sheet also shows pressure with negative equity, indicating constrained financial flexibility even with low absolute debt.

Income Statement

TTM (Trailing-Twelve-Months) revenue is positive and shows strong growth (+52.0%), but profitability remains very weak. Gross margin is modest (~17.7%), while operating results are deeply negative (EBIT and EBITDA margins roughly -4x revenue) and net margin is highly negative, indicating the current cost structure is far larger than the revenue base. Annual periods show little to no revenue, reinforcing that the business is still in an early commercialization phase and earnings quality is not yet established.

Balance Sheet

Debt levels are low in absolute terms (TTM total debt ~$37k), which limits traditional leverage risk, but the balance sheet shows instability via negative equity in TTM (about -$27.8k). Equity has also swung materially across years (positive in some annual periods, negative in others), suggesting dilution/accumulated losses and potential capital-raising dependence. With negative equity, leverage ratios are less meaningful and financial flexibility is constrained despite low debt.

Cash Flow

Cash generation is a key weakness: TTM operating cash flow (~-$3.0M) and free cash flow (~-$3.3M) are both significantly negative, and free cash flow declined versus the prior period (about -29.8% growth). Cash burn is broadly consistent with reported losses (free cash flow is ~1.11x net loss in TTM), indicating losses are translating into real cash outflows rather than being offset by working-capital benefits.

Breakdown	TTM	Jun 2025	Jun 2024	Jun 2022	Mar 2021
Income Statement
Total Revenue	697.06K	0.00	0.00	0.00	0.00
Gross Profit	123.10K	-37.57K	-68.26K	-15.25K	0.00
EBITDA	-2.87M	-5.93M	-2.18M	-2.99M	-237.32K
Net Income	-3.12M	-6.06M	-2.26M	-3.00M	-237.32K
Balance Sheet
Total Assets	2.30M	2.91M	517.08K	1.18M	288.40K
Cash, Cash Equivalents and Short-Term Investments	637.80K	1.25M	398.88K	854.43K	281.84K
Total Debt	37.18K	68.68K	74.86K	79.29K	200.00K
Total Liabilities	2.33M	2.24M	2.38M	721.60K	425.13K
Stockholders Equity	-27.84K	664.52K	-1.86M	456.28K	-136.73K
Cash Flow
Free Cash Flow	-3.31M	-7.66M	-559.92K	-2.44M	17.25K
Operating Cash Flow	-2.98M	-7.40M	-559.92K	-2.39M	17.25K
Investing Cash Flow	-325.82K	-257.76K	0.00	-51.24K	0.00
Financing Cash Flow	1.48M	8.51M	907.48K	3.01M	264.59K

UniDoc Health Corp Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.14
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:UDOC, the sentiment is Positive. The current price of 0.14 is above the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.14, and below the 200-day MA of 0.19, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 53.13 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:UDOC.

UniDoc Health Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	68 Neutral	C$494.47M	-185.55	1.45%	―	59.34%	-23.48%
CHS	53 Neutral	C$10.59M	-11.57	―	―	16.04%	-455.38%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AIDR	48 Neutral	C$56.08M	-2.31	-207.53%	―	―	7.04%
UDOC	45 Neutral	C$11.66M	-5.12	6239.15%	―	―	48.94%
NARA	42 Neutral	C$6.25M	-4.68	―	―	―	81.01%

UniDoc Health Corp Corporate Events

UniDoc Expands eHealth Footprint with H3 Health Cube Installation in Italy

UniDoc Health Corp. has successfully installed its H3 Health Cube in the Guardia Perticara Territorial eHealth Centre in Basilicata, Italy, in collaboration with its regional partner UniCheck SRL. The installation is part of a government-led eHealth initiative geared toward improving accessibility to healthcare services in underserved regions. The adaptable Health Cube was integrated into a historic site and is designed to offer primary care, specialized consultations, and diagnostic support, enhancing healthcare delivery for local communities and reinforcing UniDoc’s position as a key player in eHealth technologies.